MAVRIC VR ICD Registry

This study has been completed.
Sponsor:
Collaborator:
Medtronic
Information provided by:
Medtronic Cardiac Rhythm Disease Management
ClinicalTrials.gov Identifier:
NCT00270933
First received: December 28, 2005
Last updated: December 26, 2007
Last verified: December 2007
  Purpose

The purpose of this registry is to collect information on the health status of patients receiving Marquis/Maximo VR Implantable Cardiac Defibrillators (ICDs), how the devices are being programmed and how this correlates to clinical patient outcome.


Condition Intervention
Ventricular Tachycardia
Ventricular Fibrillation
Device: Registry

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Marquis/Maximo VR ICD Programming Practices Registry (MAVRIC VR ICD Registry)

Resource links provided by NLM:


Further study details as provided by Medtronic Cardiac Rhythm Disease Management:

Estimated Enrollment: 742
Study Start Date: January 2004
Estimated Study Completion Date: December 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients 18 years of age or older
  • Patients implanted with a new or replacement Marquis VR or Maximo VR ICD

Exclusion Criteria:

  • Patients enrolled in a device study that affects treatment and/or programming
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00270933

  Show 91 Study Locations
Sponsors and Collaborators
Medtronic Cardiac Rhythm Disease Management
Medtronic
Investigators
Principal Investigator: George Klein, M.D. London H.S.C. University Campus
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00270933     History of Changes
Other Study ID Numbers: 232
Study First Received: December 28, 2005
Last Updated: December 26, 2007
Health Authority: Canada: Ethics Review Committee
United States: Institutional Review Board

Keywords provided by Medtronic Cardiac Rhythm Disease Management:
defibrillators
LLECG
ventricular tachycardia
ventricular fibrillation

Additional relevant MeSH terms:
Tachycardia
Ventricular Fibrillation
Tachycardia, Ventricular
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on August 28, 2014